Wegovy FlexTouch Pen (Semaglutide) – Weekly Weight Loss Injection

Wegovy FlexTouch (semaglutide) is a once-weekly GLP-1 weight loss injection indicated for chronic weight management in adults with obesity or overweight with weight-related medical conditions. It helps reduce appetite, control food cravings, and increase satiety, supporting clinically proven and sustainable weight loss when combined with a reduced-calorie diet and increased physical activity.

Semaglutide, the active ingredient in Wegovy, mimics the natural GLP-1 hormone that regulates hunger and food intake in the brain. By slowing gastric emptying and enhancing fullness signals, Wegovy helps patients eat less and feel satisfied longer.

Wegovy is administered using a prefilled FlexTouch pen designed for simple once-weekly self-injection. Treatment begins with a low starting dose and is gradually increased every 4 weeks until the recommended maintenance dose of 2.4 mg weekly is reached to improve tolerability and long-term effectiveness.

Wegovy is FDA-approved and widely prescribed worldwide as an evidence-based medical weight loss treatment.

Key Benefits

• GLP-1 semaglutide medical weight loss therapy
• Reduces appetite and hunger signals
• Helps control cravings and portion size
• Increases fullness after meals
• Once-weekly convenient dosing
• Prefilled easy-to-use injection pen

How to Use

Inject Wegovy once weekly on the same day each week, at any time of day, with or without meals. Treatment starts with 0.25 mg weekly for 4 weeks, then the dose is increased every 4 weeks until reaching the maintenance dose of 2.4 mg weekly, as prescribed by your healthcare provider.

Important Information

Wegovy is a prescription medicine for weight management and should be used under medical supervision. It is intended for adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions. Not suitable during pregnancy or for patients with certain endocrine conditions unless advised by a physician.

Wegovy Frequently Asked Questions

What is Wegovy used for?
Wegovy is a prescription semaglutide injection used for chronic weight management in adults with obesity or overweight with weight-related health conditions.

How does Wegovy help with weight loss?
Wegovy contains semaglutide (GLP-1) that regulates appetite, reduces hunger, slows stomach emptying, and increases fullness after eating.

How often do you inject Wegovy?
Wegovy is injected once weekly on the same day each week, with or without meals.

What is the starting dose of Wegovy?
Treatment begins with 0.25 mg once weekly for 4 weeks, then the dose is gradually increased until reaching 2.4 mg weekly as prescribed.

Who can use Wegovy?
Adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions, under medical supervision.